ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Exploring young adult cancer survivors' perspectives on generative AI chatbots for symptom support.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundYoung adult cancer survivors (ages 18-39) often experience persistent treatment-related symptoms that negatively affect daily functioning, psychosocial well-being, and quality of life, yet report unmet educational needs for symptom management. Generative artificial intelligence (AI) technologies, such as large language model-powered chatbots, offer scalable, personalized, and empathetic symptom support but remain largely untested in young adults' survivorship care.
objectiveThis qualitative descriptive study explored young adult cancer survivors' perspectives, preferences, and experiences related to the use of generative AI chatbots for oncology symptom management.
methodsEighteen post-treatment young adult cancer survivors who had completed cancer treatment within the past two years were recruited from the University of Michigan Rogel Cancer Center. Participants completed the PROMIS-29, PROMIS Self-Efficacy for Managing Symptoms, and the Digital Health Literacy Scale to quantify symptom burden, self-efficacy, and digital readiness. Semi-structured interviews explored experiences with cancer treatment-related symptoms and AI use, including preferences for personalization, tone, functionality, and data governance.
resultsQualitative analyses revealed three themes: (1) the need for personalized, emotionally supportive, and credible AI symptom guidance; (2) accessible and user-centered design drives engagement with AI symptom support; and (3) trust, privacy, and human oversight as preconditions for AI symptom support. Survivors viewed AI as a supplemental resource to enhance symptom monitoring, decision support, and emotional reassurance without replacing clinical care.
conclusionGenerative AI chatbots were perceived as acceptable and potentially valuable for AYA symptom management. Findings can guide the development of tailored digital self-management interventions responsive to the complex and evolving needs of this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.